Ultra-Rare Cancers Partnership Launches With Two Pilot Indications, Seeks Industry Help

End to end
The ULTRA program will pursue end-to-end development of therapies for ultra-rare cancers. (Shutterstock)

More from Rare Diseases

More from United States